Clinical Trial Update: A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight [Phase 3]

View source ↗

Summary

This update describes the completion of a Phase 3 trial evaluating semaglutide for weight loss in people with obesity and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED